Research Library

State-based Medicaid programs have begun using All Patient Refined–Diagnosis-Related Groups (APR-DRGs) to determine hospital reimbursement rates. This study examined how well APR-DRGs reflect admission costs for childhood cancer chemotherapy to inform clinicians, hospitals and policymakers in the wake of policy changes.

Current medical research and literature may be overemphasizing the role that hospital volume plays in patient outcomes, according to a study co-authored by health economics fellow Vivian Ho.

This issue brief argues that continued investments in global health and the study of emerging pathogens could yield better tools to fight infectious diseases like the Zika virus long before they become a problem in the developed world.

The 340B Drug Pricing Program, which allows uninsured or low-income patients to buy prescription drugs at discounted prices, is under attack.

This paper reports the key climate change and public policy issues addressed by guest speakers during the 2014-15 Climate Lecture Series hosted by the Center for Energy Studies.

Health care providers add multiple processes to the care of complex cancer patients, believing they prevent and/or ameliorate complications. However, the relationship between these processes, complication remediation, and expenditures is unknown.

In this commentary, the authors examine the roots of the United States’ reluctance to embrace universal health care, concluding that it "is neither sound nor ethical in a nation that promulgates fairness and equal opportunity" to deny coverage.

This paper reviews the literature on asthma management programs for children and discusses the implications and recommendations for asthma management programs, future research and policy development.

Despite enviable increases in educational attainment, women in the MENA countries may fare less well in attaining a form of social capital integral to their ability to exercise full political, economic and social agency: wasta — loosely, clout, or using one’s connections and/or influence to get things done.

Asthma in children costs an estimated $27 billion annually for doctor visits, emergency department visits and hospitalizations. Not surprisingly, kids with asthma miss more days of school and do worse academically. The first step to the management and treatment of asthma is access to a primary care provider who can prescribe the necessary medications and develop an asthma action plan. However, if we want to have a significant impact on the negative consequences of this disease on our children, a multi-faceted approach that includes policy is an absolute must.